Migcef 200 DT Tablet is a broad-spectrum antibacterial agent containing cefpodoxime proxetil as the active pharmaceutical ingredient, available in a dosage form of 200mg per tablet. This cephalosporin derivative is indicated for the treatment of various bacterial infections such as community-acquired pneumonia, uncomplicated urinary tract infections, tonsillitis, pharyngitis, and acute exacerbations of chronic bronchitis. Migcef 200 DT Tablet is effective against a wide range of Gram-positive and Gram-negative bacteria, including Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, Escherichia coli, and Klebsiella pneumoniae, among others. The tablet is to be taken orally, preferably with or after meals, and the recommended dosage varies depending on the indication and patient population. Adverse reactions may include diarrhea, nausea, headache, and abdominal pain, although most are mild and self-limiting. Migcef 200 DT Tablet should be used with caution in patients with a history of kidney or liver disease, and in those receiving concomitant medications that may interact with the antibiotic. As with all antibacterial agents, it is essential to complete the full course of treatment to ensure the eradication of the underlying infection.